Hadassah

Hadassah Researchers Discover Reason For Life-Threatening Infections in Infants That Lead to Bone Marrow Failure

Tuesday, Apr 30 2013

A multidisciplinary team of researchers at the Hadassah Medical Center have discovered the reason behind recurrent life-threatening infections in infants that has led to bone marrow failure. Through six months of intensive research, Dr. Polina Stepensky, a pediatric hemato-oncology and bone marrow transplant specialist; Prof. Orly Elpeleg, head of the Department of Genetics and Metabolic Diseases; and Prof. Dror Mevorach, head of Internal Medicine B and Director of the Rheumatology Research Center, identified a gene mutation in the Vps45 gene which causes accelerated cell death in select white blood cells and bone marrow.

Additionally, they noted that the intracellular transport system in the blood cells was collapsing due to the absence of intracellular storage vesicles. The authors of the study note that "this is the first report of a Vps45-related disease in humans," which manifests itself with abnormally low levels of the white blood cells produced in the bone marrow, platelet abnormality, disorder of the bone marrow, and progressive bone marrow failure. They also bring out that "elucidation of the underlying mechanism is important because it extends our understanding of the more common adult forms of these disorders."

The researchers analyzed data from five Palestinian children who suffered from recurrent, serious infections, followed by bone marrow failure. Although they came from two unrelated families, the children were products of consanguineous marriages (sharing a common ancestry). The two older siblings, who also came to Hadassah for treatment, died prior to the study. Two of the surviving children have, however, recovered from this debilitating condition thanks to successful bone marrow transplants performed at Hadassah.

The research findings were published in the April 18, 2013 on-line edition of the prestigious medical journal, Blood , and have drawn world-wide attention.



Read about it in The Jerusalem Post>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More